vs
Side-by-side financial comparison of SAGTEC GLOBAL Ltd (SAGT) and Scilex Holding Co (SCLX). Click either name above to swap in a different company.
Scilex Holding Co is the larger business by last-quarter revenue ($4.8M vs $3.8M, roughly 1.3× SAGTEC GLOBAL Ltd). SAGTEC GLOBAL Ltd runs the higher net margin — 19.7% vs -961.9%, a 981.6% gap on every dollar of revenue.
Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.
SAGT vs SCLX — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.8M | $4.8M |
| Net Profit | $744.4K | $-46.1M |
| Gross Margin | 36.4% | 45.5% |
| Operating Margin | — | -2317.8% |
| Net Margin | 19.7% | -961.9% |
| Revenue YoY | — | -67.8% |
| Net Profit YoY | — | -613.7% |
| EPS (diluted) | $0.05 | $-4.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $4.8M | ||
| Q3 25 | $3.8M | $10.6M | ||
| Q2 25 | — | $9.9M | ||
| Q1 25 | — | $5.0M | ||
| Q4 24 | — | $14.9M | ||
| Q3 24 | — | $14.4M | ||
| Q2 24 | — | $16.4M | ||
| Q1 24 | — | $10.9M |
| Q4 25 | — | $-46.1M | ||
| Q3 25 | $744.4K | $-257.8M | ||
| Q2 25 | — | $-44.0M | ||
| Q1 25 | — | $-26.1M | ||
| Q4 24 | — | $-6.5M | ||
| Q3 24 | — | $-4.4M | ||
| Q2 24 | — | $-37.6M | ||
| Q1 24 | — | $-24.4M |
| Q4 25 | — | 45.5% | ||
| Q3 25 | 36.4% | 68.5% | ||
| Q2 25 | — | 66.9% | ||
| Q1 25 | — | 72.3% | ||
| Q4 24 | — | 68.5% | ||
| Q3 24 | — | 73.9% | ||
| Q2 24 | — | 73.2% | ||
| Q1 24 | — | 64.7% |
| Q4 25 | — | -2317.8% | ||
| Q3 25 | — | -1766.2% | ||
| Q2 25 | — | -207.2% | ||
| Q1 25 | — | -557.5% | ||
| Q4 24 | — | -190.5% | ||
| Q3 24 | — | -138.0% | ||
| Q2 24 | — | -95.4% | ||
| Q1 24 | — | -179.0% |
| Q4 25 | — | -961.9% | ||
| Q3 25 | 19.7% | -2441.5% | ||
| Q2 25 | — | -445.1% | ||
| Q1 25 | — | -521.2% | ||
| Q4 24 | — | -43.4% | ||
| Q3 24 | — | -30.4% | ||
| Q2 24 | — | -229.6% | ||
| Q1 24 | — | -224.0% |
| Q4 25 | — | $-4.63 | ||
| Q3 25 | $0.05 | $-22.17 | ||
| Q2 25 | — | $-7.42 | ||
| Q1 25 | — | $-2.26 | ||
| Q4 24 | — | $8.53 | ||
| Q3 24 | — | $-0.58 | ||
| Q2 24 | — | $-7.67 | ||
| Q1 24 | — | $-8.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $313.5K | $5.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $11.5M | $-207.8M |
| Total Assets | $14.5M | $365.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.0M | ||
| Q3 25 | $313.5K | $878.0K | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $77.0K | ||
| Q2 24 | — | $6.9M | ||
| Q1 24 | — | $1.8M |
| Q4 25 | — | $-207.8M | ||
| Q3 25 | $11.5M | $-176.9M | ||
| Q2 25 | — | $-249.0M | ||
| Q1 25 | — | $-211.5M | ||
| Q4 24 | — | $-192.6M | ||
| Q3 24 | — | $-211.3M | ||
| Q2 24 | — | $-214.7M | ||
| Q1 24 | — | $-189.8M |
| Q4 25 | — | $365.0M | ||
| Q3 25 | $14.5M | $275.9M | ||
| Q2 25 | — | $83.8M | ||
| Q1 25 | — | $79.0M | ||
| Q4 24 | — | $93.0M | ||
| Q3 24 | — | $100.4M | ||
| Q2 24 | — | $104.5M | ||
| Q1 24 | — | $91.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.2M | $-17.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 6.93× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-17.5M | ||
| Q3 25 | $5.2M | $8.2M | ||
| Q2 25 | — | $7.0M | ||
| Q1 25 | — | $6.0M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | — | $5.1M | ||
| Q2 24 | — | $2.3M | ||
| Q1 24 | — | $9.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 6.93× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
